Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;15(3):424-427.
doi: 10.1016/j.pcd.2021.01.003. Epub 2021 Jan 9.

Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people

Savas Karatas  1 , Tijen Yesim  2 , Selvihan Beysel  3
Affiliations

Impact of lockdown COVID-19 on metabolic control in type 2 diabetes mellitus and healthy people

Savas Karatas et al. Prim Care Diabetes. 2021 Jun.

Abstract

Aims: The impact of prolonged COVID-19 lockdown on metabolic control in type 2 diabetes patients and healthy individuals has not exactly been known. We aimed to evaluate the change in body weight and metabolic control in type 2 diabetic and non-diabetic healthy subjects during the prolonged lockdown period.

Methods: Diabetic (n = 85), and age-and sex-matched non-diabetic subjects (n = 55) were included in this prospective study. Body mass index and metabolic parameters were compared between before and 6th months of lockdown. Changes in values were evaluated using the difference before and after lockdown.

Results: Age (54.81 ± 10.53 vs. 52.61 ± 4.88 years), gender (female, 68.2% vs. 56.4%) and, BMI (33.44 ± 6.48 vs. 31.63 ± 3.57 kg/m2) were similar between groups (p > 0.05). Before and after lockdown, BMI increased both in non-diabetic (0.54 ± 0.95 kg) and diabetic groups (1.91 ± 5.48 kg) (p > 0.05). Increase in HbA1c was more in diabetic than in non-diabetic groups (0.71 ± 1.35 vs. 0.02 ± 0.19%, p = 0.002). Glucose, LDL-C, and TG increased in diabetic (39.69 ± 74.69, 7.60 ± 34.33, and 58.21 ± 133.54 mg/dl, p < 0.05) whereas non significantly decreased in non-diabetic group (-0.51 ± 4.40, -3.52 ± 14.53, and -6.47 ± 41.77 mg/dl, respectively. After adjusting BMI, increase in blood glucose (p = 0.021), HbA1c (p = 0.018), and TG (p = 0.041) levels were more in diabetic than non-diabetic group. Duration of diabetes was an independent predictor of the change in HbA1c (OR: 1.2, 95% CI = 1.1-1.8, p = 0.032).

Conclusions: Body weight gain was observed in type 2 diabetic patients and healthy subjects. This is the first study to show that prolonged lockdown COVID-19 pandemic worsened glucose regulation and increased TG level in diabetes mellitus independent of weight gain.

Keywords: COVİD-19 lockdown; Diabetes; Metabolic disorders; Weight gain.

PubMed Disclaimer

References

    1. Ghosh A., Arora B., Gupta R. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in North India. Diabetes Metab. Syndr. Clin. Res. Rev. 2020;5:917–920. doi: 10.1016/j.dsx.2020.05.044. - DOI - PMC - PubMed
    1. Ghosal S., Arora B., Dutta K. Increase in the risk of type 2 diabetes during lockdown for the COVID19 pandemic in India: a cohort analysis. Diabetes Metab. Syndr. 2020;14:949–952. doi: 10.1016/j.dsx.2020.06.020. - DOI - PMC - PubMed
    1. Singhai K., Swami M.K., Nebhinani N. Psychological adaptive difficulties and their management during COVID-19 pandemic in people with diabetes mellitus. Diabetes Metab. Syndr. 2020;14:1603–1605. doi: 10.1016/j.dsx.2020.08.025. - DOI - PMC - PubMed
    1. Holman N., Knighton P., Kar P. Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Lancet Diabetes Endocrinol. 2020;8(10):823–833. doi: 10.1016/S2213-8587(20)30271-0. - DOI - PMC - PubMed
    1. Rastogi A., Hiteshi P., Bhansali A. Improved glycemic control amongst people with long-standing diabetes during COVID-19 lockdown: a prospective, observational, nested cohort study. Int. J. Diabetes Dev. 2020;1:6. doi: 10.1007/s13410-020-00880-x. - DOI - PMC - PubMed